Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 24Lymphoma, Non-Hodgkin 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Lymphoma, Large B-Cell, Diffuse 13Leukemia, Myeloid, Acute 9Leukemia 9Neuroblastoma 8Leukemia, Lymphocytic, Chronic, B-Cell 8Hodgkin Disease 8Central Nervous System Neoplasms 8Medulloblastoma 7Rhabdoid Tumor 6Recurrence 6Multiple Myeloma 6Lymphoma, Mantle-Cell 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, B-Cell, Marginal Zone 6Burkitt Lymphoma 6Neoplasms, Germ Cell and Embryonal 5Lymphoma, Follicular 5Lymphoma, B-Cell 5Glioma 5Brain Neoplasms 5Sarcoma 4Ovarian Neoplasms 4Oligodendroglioma 4Neoplasms 4Lung Neoplasms 4Immunoblastic Lymphadenopathy 4Astrocytoma 4

Interventions

Rituximab 5fludarabine 4Tacrolimus 4Epoetin Alfa 4Cyclophosphamide 4Busulfan 4Darbepoetin alfa 3Alemtuzumab 3fludarabine phosphate 2entrectinib 2atezolizumab 2alectinib 2Thiotepa 2Therapeutics 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Methotrexate 2Etoposide 2Early Intervention, Educational 2Cytarabine 2Bortezomib 2Antilymphocyte Serum 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2venetoclax 1trametinib 1tirbanibulin 1sargramostim 1plerixafor 1phenethyl isothiocyanate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphoproliferative Disorders × etoposide phosphate × Clear all
NCT06954805 2026-05-27

Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

Columbia University

Phase 2 Recruiting
30 enrolled
Lymphoid

Lymphoma, Lymphoproliferative Disorders, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡